MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2024 International Congress

    The Impact of Camp Lejeune Toxins on the Development of Parkinsonisms and Movement Disorders

    K. Colletta, J. Hirschey, A. Raedy, A. Siddiqui, F. Weaver, S. Kletzel (Hines, USA)

    Objective: To further characterize movement disorders seen in Veterans exposed to toxins at Camp Lejeune military base. Background: Recent reports reveal that water in the…
  • 2024 International Congress

    Comparison of Composite Method Calculations for Monitoring Disease Progression in Early Parkinson’s Disease

    M. Czech, L. Yang, J. Shen, M. Crouthamel, T. Kangarloo, J. Adams, R. Dorsey, J. Cosman (North Chicago, USA)

    Objective: Objective: To evaluate the influence of composite scoring methodologies using digital measures of gait, tremor, and bradykinesia to monitor disease progression over one year…
  • 2024 International Congress

    Parkinsonism due to Adult-Onset Leukoencephalopathy with Axonal Spheroids and Pigmented Glia (ALSP) Responsive to Carbidopa/Levodopa

    P. Hoff, F. Butt (Oklahoma City, USA)

    Objective: To describe a case of Parkinsonism due to ALSP which is responsive to carbidopa/levodopa Background: Adult-Onset Leukoencephalopathy with Axonal Spheroids and Pigmented Glia (ALSP)…
  • 2024 International Congress

    The impact of cognitive impairment and Alzheimer’s disease neuropathological changes on gait and falls in Parkinson’s disease

    J. Parmera, P. Cullinane, S. Wrigley, T. Revesz, Z. Jaunmuktane, T. Warner, E. de Pablo-Fernandez (London, United Kingdom)

    Objective: To investigate the association between clinical markers of cognitive impairment, severity, and distribution of Alzheimer's disease neuropathological changes (ADNC) with gait difficulties, freezing of…
  • 2024 International Congress

    Creation and Performance of a Cognitive Summary Score in de novo Parkinson’s Disease: Results from the PPMI Study

    M. Brumm, R. Kurth, M. York, D. Weintraub ()

    Objective: To determine if a cognitive summary score (CSS) is sensitive in detecting early cognitive deficits in de novo Parkinson’s disease (PD). Background: Cognitive impairment…
  • 2024 International Congress

    Characterisation and longitudinal significance of subjective cognitive decline in GBA and LRRK2 Parkinson’s disease

    L. Batzu, D. Urso, S. Rota, A. Podlewska, MA. Qamar, KR. Chaudhuri (London, United Kingdom)

    Objective: To investigate the clinical characteristics and predictive value associated with subjective cognitive decline (SCD) in people with Parkinson’s disease (PD) carrying pathogenic GBA or…
  • 2024 International Congress

    Semantic Memory in Parkinson’s Disease: Linguistic Features and Neural Correlates

    F. Toro-Hernández, J. Migeot, N. Marchant, D. Olivares, F. Ferrante, R. González-Gómez, C. González Campo, S. Fittipaldi, G. Rojas-Costa, S. Moguilner, A. Slachevsky, P. Chaná Cuevas, A. Ibáñez, S. Chaigneau, A. García (São Paulo, Brazil)

    Objective: This study aims to characterize behavioral and neural correlates of semantic processing in Parkinson’s disease (PD). Background: Cognitive studies on PD reveal abnormalities during…
  • 2024 International Congress

    Integrating Non-Motor Symptoms and Gender Variability in Machine Learning for Early Parkinson’s Disease Detection

    MZA. Ali, PSD. Dholaniya (Hyderabad, India)

    Objective: Our study aimed to develop a machine learning (ML) model for the early detection of Parkinson's disease (PD), utilizing non-motor symptoms (NMS) and DNA…
  • 2024 International Congress

    Autonomic Dysfunction in Parkinson’s Disease Link with disease severity and other non-motor signs

    A. Mousli, R. Zouari, A. Rachdi, F. Nabli, D. Ben Mohamed, Z. Saeid, S. Ben Sassi (Ariana, Tunisia)

    Objective: Clarify the relationship between autonomic dysfunction, disease severity and NMS in PD patients. Background: Parkinson’s disease (PD) is characterized by a combination of motor…
  • 2024 International Congress

    Validation of the International Parkinson and Movement Disorder Society – Non-Motor Symptoms – Questionnaire (MDS-NMS-Q)

    D. Weintraub, KR. Chaudhuri, A. Schrag, P. Martinez-Martin, A. Rizos, E. Mamikonyan, J. Gallagher, J. Staunton, M. Pereira Fernandes, C. Rodriguez Blazquez (Philadelphia, USA)

    Objective: To validate the self-completed version of the International Movement Disorder Society – Non-Motor Rating Scale (MDS-NMS)1, named the MDS-NMS – Questionnaire (MDS-NMS-Q). Background: The…
  • « Previous Page
  • 1
  • …
  • 169
  • 170
  • 171
  • 172
  • 173
  • …
  • 181
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • An atypical and interesting feature of Parkinson´s disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • An atypical and interesting feature of Parkinson´s disease
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley